Tag: gemini pharmaceuticals

Gemini Pharmaceuticals has been granted preliminary approval from the Suffolk County Industrial Development Agency for financial incentives that will assist with $13.9 million in renovations to four properties. 

The 43-year-old family-owned manufacturer of over-the-counter pharmaceutical, nutraceutical and animal health products is planning infrastructure improvements and other upgrades that aim to expand its operations. 

The projects include repurposing underutilized office space to create about 4,000 square feet of R&D and support space at 65 Mall Drive in Commack; replacing an aging 5,500-gallon wastewater tank with a direct municipal sewer connection at 55 Adams Ave. in Hauppauge; enhancements to the company’s manufacturing facility at 81 Modular Drive in Commack; and renovations of its corporate headquarters at 87 Modular Ave. in Commack, according to Gemini’s IDA application. 

“This project not only strengthens Gemini Pharmaceuticals’ future but also fuels the continued growth of Suffolk County’s already robust pharmaceutical industry,” Kelly Murphy, executive director of the Suffolk IDA, said in an agency statement. “By supporting strategic investments like this, we’re ensuring that Suffolk remains a hub for innovation, high-quality jobs, and long-term economic vitality.” 

The project is expected to retain 256 jobs and create an additional 50 jobs over the next two years. It is projected to be completed in 2027. 

“We are truly grateful for the support of the Suffolk County IDA,” Michael Finamore, CEO of Gemini Pharmaceuticals, said in the statement. “This project would not be possible without their partnership. With this investment, we can upgrade our facilities, expand our capabilities, and continue to provide stable, high-quality jobs here in Suffolk County.”